Thaweesak Chieochansin
Overview
Explore the profile of Thaweesak Chieochansin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
982
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wathikthinnakon M, Luangwattananun P, Sawasdee N, Chiawpanit C, Lee V, Nimmanpipug P, et al.
Sci Rep
. 2025 Feb;
15(1):4515.
PMID: 39915564
No abstract available.
2.
Chieochansin T, Sanachai K, Darai N, Chiraphapphaiboon W, Choomee K, Yenchitsomanus P, et al.
Heliyon
. 2024 Sep;
10(17):e36654.
PMID: 39263056
Our study employed molecular dynamics (MD) simulations to assess the binding affinity between short peptides derived from the tumor-associated antigen glypican 3 (GPC3) and the major histocompatibility complex (MHC) molecule...
3.
Luangwattananun P, Sangsuwannukul T, Supimon K, Thuwajit C, Chieochansin T, Sa-Nguanraksa D, et al.
Int Immunopharmacol
. 2023 Oct;
124(Pt B):111012.
PMID: 37804657
T cell-based immunotherapy has transformed cancer treatment. Nonetheless, T cell antitumor activity can be inhibited by an immune checkpoint molecule expressed on cancer cells, program death ligand 1 (PD-L1), which...
4.
Phikulsod P, Sukpanichnant S, Kunacheewa C, Chieochansin T, Junking M, Yenchitsomanus P
Pathol Oncol Res
. 2023 Feb;
29:1610844.
PMID: 36760714
Wilms tumor 1 (WT1) is a promising target antigen for cancer immunotherapy. However, WT1 protein expression and its clinical correlation in multiple myeloma (MM) patients are still limited. We, therefore,...
5.
Yuti P, Wutti-In Y, Sawasdee N, Kongkhla K, Phanthaphol N, Choomee K, et al.
Int Immunopharmacol
. 2022 Nov;
113(Pt B):109442.
PMID: 36435066
Adoptive T cell therapy using second-generation anti-CD19 chimeric antigen receptor T cells (anti-CD19-CAR2-T) induced complete remission in many heavily pretreated patients with B cell acute lymphoblastic leukemia (B-ALL) or diffuse...
6.
Supimon K, Sangsuwannukul T, Sujjitjoon J, Chieochansin T, Junking M, Yenchitsomanus P
Cytotherapy
. 2022 Nov;
25(2):148-161.
PMID: 36396553
Background Aims: Cholangiocarcinoma (CCA) is a lethal bile-duct cancer that is difficult to treat by current standard procedures. This drawback has prompted us to develop adoptive T-cell therapy for CCA,...
7.
Tarasuk M, Songprakhon P, Chieochansin T, Choomee K, Na-Bangchang K, Yenchitsomanus P
Sci Rep
. 2022 Sep;
12(1):16088.
PMID: 36168031
Severe dengue virus (DENV) infection results from viral replication and dysregulated host immune response, which trigger massive cytokine production/cytokine storm. The result is severe vascular leakage, hemorrhagic diathesis, and organ...
8.
Jirapongwattana N, Thongchot S, Chiraphapphaiboon W, Chieochansin T, Sa-Nguanraksa D, Warnnissorn M, et al.
Oncol Rep
. 2022 May;
48(1).
PMID: 35616135
Triple negative breast cancer (TNBC) lacks targeted treatment resulting in poor prognosis. Targeting overexpressing mesothelin (MSLN) using MSLN‑specific T cells is an attractive treatment approach and the aim of the...
9.
Wathikthinnakon M, Luangwattananun P, Sawasdee N, Chiawpanit C, Lee V, Nimmanpipug P, et al.
Sci Rep
. 2022 Apr;
12(1):6154.
PMID: 35418130
Cholangiocarcinoma (CCA) is a lethal cancer with rapid progression and poor survival. Novel and more effective therapies than those currently available are, therefore, urgently needed. Our research group previously reported...
10.
Chiraphapphaiboon W, Luangwattananun P, Panya A, Jirapongwattana N, Punnakitikashem P, Chieochansin T, et al.
Anticancer Res
. 2022 Mar;
42(4):1785-1799.
PMID: 35346997
Background/aim: B cell maturation antigen (BCMA) is an ideal target for adoptive T cell therapy of multiple myeloma (MM). In this study, we evaluated self-differentiated monocyte-derived dendritic cells expressing BCMA...